NextGen to Offer Biomarker Services; Taps Pisano as CEO | GenomeWeb
NEW YORK (GenomeWeb News) - NextGen Sciences said today that it will now offer protein biomarker services, including assay development and validation, and that it has named Mike Pisano, the former head of Protein Research Services, to be CEO of the company.
 
NextGen said its biomarker services are supported by the proteomics know-how that it acquired when it bought PRS in 2006, and by its investments into technologies such as ThermoFisher’s OrbiTrap and its triple quad mass spectrometers.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.